# A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy Volunteers

> **NCT01603342** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 18 (actual)

## Conditions studied

- Haemostasis
- Healthy

## Interventions

- **DRUG:** clopidogrel
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01603342
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01603342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01603342, "A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01603342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*